The metastatic phenotype - development of new tools in cancer diagnosis, prediction and therapy
- Prosjektnummer
- 2011090
- Ansvarlig person
- Gunhild Mari Mælandsmo
- Institusjon
- Oslo universitetssykehus HF
- Prosjektkategori
- Helse Sør-Øst Forskningsgruppe
- Helsekategori
- Cancer
- Forskningsaktivitet
- 4. Detection and Diagnosis, 5. Treatment Developement
Differential in vivo tumorigenicity of distinct subpopulations from a luminal-like breast cancer xenograft.
PLoS One 2014;9(11):e113278. Epub 2014 nov 24
PMID: 25419568
Patient-derived xenograft models: an emerging platform for translational cancer research.
Cancer Discov 2014 Sep;4(9):998-1013. Epub 2014 jul 15
PMID: 25185190
Positron emission tomography and pharmacokinetics of 2-[18F]-fluoroethyl choline for metabolic studies in breast cancer xenografts.
Acta Oncol 2014 Aug;53(8):1086-92. Epub 2014 jul 14
PMID: 25017377
Interplay of choline metabolites and genes in patient-derived breast cancer xenografts.
Breast Cancer Res 2014;16(1):R5. Epub 2014 jan 21
PMID: 24447408
Metastasis-associated protein S100A4 induces a network of inflammatory cytokines that activate stromal cells to acquire pro-tumorigenic properties.
Cancer Lett 2014 Mar 1;344(1):28-39. Epub 2013 nov 8
PMID: 24215866
Proteomic characterization of breast cancer xenografts identifies early and late bevacizumab-induced responses and predicts effective drug combinations.
Clin Cancer Res 2014 Jan 15;20(2):404-12. Epub 2013 nov 5
PMID: 24192926
Association between use of ß-blockers and prostate cancer-specific survival: a cohort study of 3561 prostate cancer patients with high-risk or metastatic disease.
Eur Urol 2014 Mar;65(3):635-41. Epub 2013 jan 14
PMID: 23351721
The architecture and evolution of cancer neochromosomes.
Cancer Cell 2014 Nov 10;26(5):653-67. Epub 2014 nov 10
PMID: 25517748
Generation and characterisation of novel pancreatic adenocarcinoma xenograft models and corresponding primary cell lines.
PLoS One 2014;9(8):e103873. Epub 2014 aug 22
PMID: 25148029
Mobile DNA in cancer. Extensive transduction of nonrepetitive DNA mediated by L1 retrotransposition in cancer genomes.
Science 2014 Aug 1;345(6196):1251343.
PMID: 25082706
Performance comparison of four exome capture systems for deep sequencing.
BMC Genomics 2014;15():449. Epub 2014 jun 9
PMID: 24912484
The regulatory landscape of osteogenic differentiation.
Stem Cells 2014 Oct;32(10):2780-93.
PMID: 24898411
Reexpression of LSAMP inhibits tumor growth in a preclinical osteosarcoma model.
Mol Cancer 2014;13():93. Epub 2014 apr 28
PMID: 24885297
Generation and characterization of an immortalized human mesenchymal stromal cell line.
Stem Cells Dev 2014 Oct 1;23(19):2377-89. Epub 2014 jun 30
PMID: 24857590
The tankyrase-specific inhibitor JW74 affects cell cycle progression and induces apoptosis and differentiation in osteosarcoma cell lines.
Cancer Med 2014 Feb;3(1):36-46. Epub 2013 des 17
PMID: 24403055
Melanoma brain colonization involves the emergence of a brain-adaptive phenotype.
Oncoscience 2014;1(1):82-94. Epub 2014 jan 10
PMID: 25593989
Differential protein network analysis of the immune cell lineage.
Biomed Res Int 2014;2014():363408. Epub 2014 sep 21
PMID: 25309909
Identifying pathogenic processes by integrating microarray data with prior knowledge.
BMC Bioinformatics 2014;15():115. Epub 2014 apr 24
PMID: 24758699
From proteomes to complexomes in the era of systems biology.
Proteomics 2014 Jan;14(1):24-41.
PMID: 24243660
HiBrowse: multi-purpose statistical analysis of genome-wide chromatin 3D organization.
Bioinformatics 2014 Jun 1;30(11):1620-2. Epub 2014 feb 7
PMID: 24511080
The MOC31PE immunotoxin reduces cell migration and induces gene expression and cell death in ovarian cancer cells.
J Ovarian Res 2014;7():23. Epub 2014 feb 15
PMID: 24528603
Osteopontin is a prognostic biomarker in non-small cell lung cancer.
BMC Cancer 2013;13():540. Epub 2013 nov 11
PMID: 24215488
Antitumor activity of elacytarabine combined with bevacizumab, cetuximab and trastuzumab in human NSCLC xenografts.
Anticancer Res 2013 Sep;33(9):3615-21.
PMID: 24023287
Dynamic (18)F-FDG-PET for monitoring treatment effect following anti-angiogenic therapy in triple-negative breast cancer xenografts.
Acta Oncol 2013 Oct;52(7):1566-72. Epub 2013 aug 29
PMID: 23984812
Clinical significance of disseminated tumour cells in non-small cell lung cancer.
Br J Cancer 2013 Sep 3;109(5):1264-70. Epub 2013 aug 13
PMID: 23942067
Low-molecular contrast agent dynamic contrast-enhanced (DCE)-MRI and diffusion-weighted (DW)-MRI in early assessment of bevacizumab treatment in breast cancer xenografts.
J Magn Reson Imaging 2013 Nov;38(5):1043-53. Epub 2013 mar 21
PMID: 23908122
Molecular circuit involving KLK4 integrates androgen and mTOR signaling in prostate cancer.
Proc Natl Acad Sci U S A 2013 Jul 9;110(28):E2572-81. Epub 2013 jun 24
PMID: 23798432
Nuclear legumain activity in colorectal cancer.
PLoS One 2013;8(1):e52980. Epub 2013 jan 10
PMID: 23326369
Subtype-specific response to bevacizumab is reflected in the metabolome and transcriptome of breast cancer xenografts.
Mol Oncol 2013 Feb;7(1):130-42. Epub 2012 okt 23
PMID: 23142657
Predicting physical interactions between protein complexes.
Mol Cell Proteomics 2013 Jun;12(6):1723-34. Epub 2013 feb 25
PMID: 23438732
The Genomic HyperBrowser: an analysis web server for genome-scale data.
Nucleic Acids Res 2013 Jul;41(Web Server issue):W133-41. Epub 2013 apr 30
PMID: 23632163
Ten simple rules for reproducible computational research.
PLoS Comput Biol 2013 Oct;9(10):e1003285. Epub 2013 okt 24
PMID: 24204232
Enhancing nucleic acid delivery by photochemical internalization.
Ther Deliv 2013 Sep;4(9):1125-40.
PMID: 24024512
Light-controlled modulation of gene expression using polyamidoamine formulations.
Nucleic Acid Ther 2013 Apr;23(2):160-5. Epub 2013 mar 26
PMID: 23530684
Evaluation of biodegradable peptide carriers for light-directed targeting.
Nucleic Acid Ther 2013 Apr;23(2):131-9. Epub 2013 feb 13
PMID: 23405950
Light-induced mRNA transfection.
Methods Mol Biol 2013;969():89-100.
PMID: 23296929
Common fusion transcripts identified in colorectal cancer cell lines by high-throughput RNA sequencing.
Transl Oncol 2013;6(5):546-53. Epub 2013 okt 1
PMID: 24151535
Deep Sequencing the MicroRNA Transcriptome in Colorectal Cancer.
PLoS One 2013;8(6):e66165. Epub 2013 jun 18
PMID: 23824282
Functional characterisation of osteosarcoma cell lines and identification of mRNAs and miRNAs associated with aggressive cancer phenotypes.
Br J Cancer 2013 Oct 15;109(8):2228-36. Epub 2013 sep 24
PMID: 24064976
Epigenetic regulation and functional characterization of microRNA-142 in mesenchymal cells.
PLoS One 2013;8(11):e79231. Epub 2013 nov 13
PMID: 24236112
Comparison of glioma stem cells to neural stem cells from the adult human brain identifies dysregulated Wnt- signaling and a fingerprint associated with clinical outcome.
Exp Cell Res 2013 Aug 15;319(14):2230-43. Epub 2013 jun 18
PMID: 23791939
Correlation of TP53 and MDM2 genotypes with response to therapy in sarcoma.
Cancer 2013 Mar 1;119(5):1013-22. Epub 2012 nov 16
PMID: 23165797
Immunotoxin targeting EpCAM effectively inhibits peritoneal tumor growth in experimental models of mucinous peritoneal surface malignancies.
Int J Cancer 2013 Sep;133(6):1497-506. Epub 2013 apr 17
PMID: 23494569
Reply to Chris R. Cardwell, Samy Suissa and Liam J. Murray's letter to the editor re: Helene Hartvedt Grytli, Morten Wang Fagerland, Sophie D. Fosså, Kristin Austlid Taskén. Association between use of ß-blockers and prostate cancer-specific survival: a cohort study of 3561 prostate cancer patients with high-risk or metastatic disease. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2013.01.007.
Eur Urol 2013 Jul;64(1):e11-2. Epub 2013 apr 11
PMID: 23602404
Use of ß-blockers is associated with prostate cancer-specific survival in prostate cancer patients on androgen deprivation therapy.
Prostate 2013 Feb 15;73(3):250-60. Epub 2012 jul 20
PMID: 22821802
TWIST1, A novel androgen-regulated gene, is a target for NKX3-1 in prostate cancer cells.
Cancer Cell Int 2013;13(1):4. Epub 2013 jan 31
PMID: 23368843
Low-dose anisomycin sensitizes melanoma cells to TRAIL induced apoptosis.
Cancer Biol Ther 2013 Feb;14(2):146-54. Epub 2012 nov 28
PMID: 23192275
Dacarbazine and the agonistic TRAIL receptor-2 antibody lexatumumab induce synergistic anticancer effects in melanoma.
PLoS One 2012;7(9):e45492. Epub 2012 sep 20
PMID: 23029050
Intra- and extracellular regulation of activity and processing of legumain by cystatin E/M.
Biochimie 2012 Dec;94(12):2590-9. Epub 2012 aug 10
PMID: 22902879
Expression of S100A4, ephrin-A1 and osteopontin in non-small cell lung cancer.
BMC Cancer 2012;12():333. Epub 2012 aug 1
PMID: 22853000
EMMPRIN is associated with S100A4 and predicts patient outcome in colorectal cancer.
Br J Cancer 2012 Aug;107(4):667-74. Epub 2012 jul 10
PMID: 22782346
Effect of antiangiogenic therapy on tumor growth, vasculature and kinase activity in basal- and luminal-like breast cancer xenografts.
Mol Oncol 2012 Aug;6(4):418-27. Epub 2012 mar 31
PMID: 22521242
Cytoplasmic BRMS1 expression in malignant melanoma is associated with increased disease-free survival.
BMC Cancer 2012;12():73. Epub 2012 feb 22
PMID: 22356677
In vivo MRI and histopathological assessment of tumor microenvironment in luminal-like and basal-like breast cancer xenografts.
J Magn Reson Imaging 2012 May;35(5):1098-107. Epub 2011 des 14
PMID: 22170753
B7-H3 contributes to the metastatic capacity of melanoma cells by modulation of known metastasis-associated genes.
Int J Cancer 2012 May;130(10):2282-90. Epub 2011 aug 8
PMID: 21671471
The effects of short-term genistein intervention on prostate biomarker expression in patients with localised prostate cancer before radical prostatectomy.
Br J Nutr 2012 Dec;108(12):2138-47. Epub 2012 mar 8
PMID: 22397815
Integrative analysis reveals relationships of genetic and epigenetic alterations in osteosarcoma.
PLoS One 2012;7(11):e48262. Epub 2012 nov 7
PMID: 23144859
Modulation of the osteosarcoma expression phenotype by microRNAs.
PLoS One 2012;7(10):e48086. Epub 2012 okt 25
PMID: 23133552
Characterization of liposarcoma cell lines for preclinical and biological studies.
Sarcoma 2012;2012():148614. Epub 2012 jul 14
PMID: 22911243
Global gene expression profiling of human osteosarcomas reveals metastasis-associated chemokine pattern.
Sarcoma 2012;2012():639038. Epub 2012 feb 28
PMID: 22518090
Adipocyte differentiation of human bone marrow-derived stromal cells is modulated by microRNA-155, microRNA-221, and microRNA-222.
Stem Cells Dev 2012 Apr;21(6):873-83. Epub 2011 aug 24
PMID: 21756067
Preclinical xenograft models of human sarcoma show nonrandom loss of aberrations.
Cancer 2012 Jan;118(2):558-70. Epub 2011 jun 28
PMID: 21713766
Tumor phosphatidylinositol-3-kinase signaling and development of metastatic disease in locally advanced rectal cancer.
PLoS One 2012;7(11):e50806. Epub 2012 nov 30
PMID: 23226389
Clinical relevance of microRNA miR-21, miR-31, miR-92a, miR-101, miR-106a and miR-145 in colorectal cancer.
BMC Cancer 2012;12():505. Epub 2012 nov 2
PMID: 23121918
B7-H3 expression in colorectal cancer: nuclear localization strongly predicts poor outcome in colon cancer.
Int J Cancer 2012 Dec;131(11):2528-36. Epub 2012 apr 24
PMID: 22473715
Investigation of nonspecific cross-reacting antigen 2 as a prognostic biomarker in bone marrow plasma from colorectal cancer patients.
Tumour Biol 2012 Feb;33(1):73-83. Epub 2011 okt 18
PMID: 22006279
Disseminated tumour cells in bone marrow of patients with uveal melanoma.
Acta Ophthalmol 2013 Jun;91(4):343-8. Epub 2012 mai 25
PMID: 22632270
Understanding the melanocyte distribution in human epidermis: an agent-based computational model approach.
PLoS One 2012;7(7):e40377. Epub 2012 jul 9
PMID: 22792296
Pathway analysis of genetic markers associated with a functional MRI faces paradigm implicates polymorphisms in calcium responsive pathways.
Neuroimage 2013 Apr 15;70():143-9. Epub 2012 des 27
PMID: 23274185
CellLineMiner: a knowledge portal for human cell lines.
Bioinformation 2012;8(22):1119-22. Epub 2012 nov 13
PMID: 23251048
[Genome sequencing for personalized cancer treatment].
Tidsskr Nor Laegeforen 2012 Nov;132(21):2406-8.
PMID: 23160594
Potent gene silencing in vitro at physiological pH using chitosan polymers.
Nucleic Acid Ther 2012 Apr;22(2):96-102.
PMID: 22480314
Towards a quantitative understanding of the MITF-PIAS3-STAT3 connection.
BMC Syst Biol 2012;6():11. Epub 2012 feb 8
PMID: 22316093
Performance comparison of multiple microarray platforms for gene expression profiling.
Methods Mol Biol 2012;802():141-55.
PMID: 22130879
Lysine methylation of VCP by a member of a novel human protein methyltransferase family.
Nat Commun 2012;3():1038.
PMID: 22948820
Strongly amphiphilic photosensitizers are not substrates of the cancer stem cell marker ABCG2 and provides specific and efficient light-triggered drug delivery of an EGFR-targeted cytotoxic drug.
J Control Release 2012 Apr;159(2):197-203. Epub 2012 feb 10
PMID: 22349185
The metastasis-promoting protein S100A4 regulates mammary branching morphogenesis.
Dev Biol 2011 Apr;352(2):181-90. Epub 2010 des 31
PMID: 21195708
Analysis of EpCAM positive cells isolated from sentinel lymph nodes of breast cancer patients identifies subpopulations of cells with distinct transcription profiles.
Breast Cancer Res 2011;13(4):R75. Epub 2011 aug 4
PMID: 21816090
Genome wide single cell analysis of chemotherapy resistant metastatic cells in a case of gastroesophageal adenocarcinoma.
BMC Cancer 2011;11():455. Epub 2011 okt 20
PMID: 22014070
Synergistic anticancer effects of the 9.2.27PE immunotoxin and ABT-737 in melanoma.
PLoS One 2011;6(9):e24012. Epub 2011 sep 7
PMID: 21915275
Triphenylmethyl derivatives enhances the anticancer effect of immunotoxins.
J Immunother 2011 Jun;34(5):438-47.
PMID: 21577141
Osteopontin--an important downstream effector of S100A4-mediated invasion and metastasis.
Int J Cancer 2011 Aug;129(4):780-90. Epub 2011 mar 11
PMID: 20957651
Coexpression and nuclear colocalization of metastasis-promoting protein S100A4 and p53 without mutual regulation in colorectal carcinoma.
Amino Acids 2011 Oct;41(4):875-84. Epub 2010 feb 27
PMID: 20191297
Targeting inhibitor of apoptosis proteins in combination with dacarbazine or TRAIL in melanoma cells.
Cancer Biol Ther 2011 Jul;12(1):47-58. Epub 2011 jul 1
PMID: 21508672
B7-H3 and its relevance in cancer; immunological and non-immunological perspectives.
Front Biosci (Elite Ed) 2011;3():989-93. Epub 2011 jun 1
PMID: 21622107
B7-H3 silencing increases paclitaxel sensitivity by abrogating Jak2/Stat3 phosphorylation.
Mol Cancer Ther 2011 Jun;10(6):960-71. Epub 2011 apr 25
PMID: 21518725
Regulation of PBX3 expression by androgen and Let-7d in prostate cancer.
Mol Cancer 2011;10():50. Epub 2011 mai 6
PMID: 21548940
Antitumour activity of oral E7080, a novel inhibitor of multiple tyrosine kinases, in human sarcoma xenografts.
Int J Cancer 2011 Aug;129(3):742-50. Epub 2011 mar 25
PMID: 21225632
Systematic evaluation of three microRNA profiling platforms: microarray, beads array, and quantitative real-time PCR array.
PLoS One 2011;6(2):e17167. Epub 2011 feb 11
PMID: 21347261
Tumor-infiltrating macrophages are associated with metastasis suppression in high-grade osteosarcoma: a rationale for treatment with macrophage activating agents.
Clin Cancer Res 2011 Apr;17(8):2110-9. Epub 2011 mar 3
PMID: 21372215
mRNA expression profiles of primary high-grade central osteosarcoma are preserved in cell lines and xenografts.
BMC Med Genomics 2011;4():66. Epub 2011 sep 20
PMID: 21933437
MDM2 antagonist Nutlin-3a potentiates antitumour activity of cytotoxic drugs in sarcoma cell lines.
BMC Cancer 2011;11():211:1-11. Epub 2011 mai 30
PMID: 21624110
Metabolic reprogramming of metastatic breast cancer and melanoma by let-7a microRNA
Oncotaget, published online 29 Des 14
Seks nye våpen mot kreft
VG, 5.04.2013
Tester skreddersydd kreftbehandling
forskningsrådet.no, 01.03.2013
kreftforskning gir nytt håp
Ekko, NRK P2, 04.12.13
Moderne kreftdiagnose skjer på datamaskinen
Apollon, forskningsmagasinet, 25.11.2013
Movember-bartene vokser videre
NRK Nyhetene , October 24th 2013
Prostate Cancer’s nerves
Science-Business eXchange, August 1st 2013
Prostate Cancers get nerved up
Cancer Discovery, July 25, 2013; doi: 10.1158/2159-8290
Blood pressure tablets can slash cancer risk
EXPRESS Home of the daily and sunday express, May20th 2013
Functional heterogeneity within a breast cancer model
Invited speaker, Norwegian stem cell Networking meeting, Oslo, 2012
Tumor microenvironment and its role in metastasis and drug-response; Emerging Role in cancer therapy
Invited speaker, EUmeet, 2012
The role of HMGA2 in cancer: EMT, stem cells and cancer progression
Global Academic programs, Oslo 2012
Identification of fusion transcripts in osteosarcoma by RNA sequencing
Global Academic programs, Oslo 2012
Characterization of Liposarcoma cell lines forpreclinical and biological studies
Global Academic programs, Oslo 2012
Stem cell related work in Myklebost's group
Stem cell center, minisymposium, 2012
FUGE konsortiet, Nuclear programming
Forskning.no, 2012
På vei mot persontilpasset kreftmedisin
Sammen mot kreft, Nr 4 (2012)
Personalized medicine
Personlized medicine conference, Harvard, nov 2012
Norway invests in personalized cancer care
Biotech scandinavia, Dec, 2012
persontilpasset kreftmedisin
Forskning.no, 2012
Blodtrykksmedisin kan hjelpe mot prostatakreft
NRK.no, okt, 2012
S100A4 - small actor playing many roles
Global Academic Programs, Oslo 2012
Norway to bring cancer-gene tests into the clinic
Februar 2012, 2 utg "Nature", feature article.
Vi kan hindre kreftspredning
www.forskning.no, januar 2011
På sporet av spredningsgåten
www.forskning.no, januar 2011
Utfordrer kreftteori
www.forskning.no, mai 2011
Skal kartlegge kreftgenar hos 4000 nordmenn
NRK morgennytt, 8. februar, 2012
prognostic biomarkers and disseminated tumor cells in early stage non-small cell lung cancer
- Disputert:
- juni 2014
- Hovedveileder:
- Gunhild Mælandsmo
Rectal cancer-Functional Molecular Profiling and Targeting og Tumor Hypoxia in radiation Response and Metastasis
- Disputert:
- juni 2014
- Hovedveileder:
- Kjersti Flatmark
MicroRNAs in mesenchymal biology and differentiation
- Disputert:
- april 2014
- Hovedveileder:
- Ola Myklebost
Signal Transduction Induced by S100A4; Activation of NF-?B and Epidermal Growth Factor Receptor.
- Disputert:
- oktober 2013
- Hovedveileder:
- Gunhild Mælandsmo
Light-directed delivery of nucleic acids with biodegradable carriers.
- Disputert:
- oktober 2013
- Hovedveileder:
- Johannes Eivind Hovig
Prostate Cancer Progression and Mortality- Focus on ß-blocker use and ß2-adrenergic receptor level.
- Disputert:
- april 2013
- Hovedveileder:
- Kristin Austlid Tasken
Integrative epigenome analysis
- Disputert:
- desember 2013
- Hovedveileder:
- Johannes Eivind Hovig
Studies of genome-wide patterns of gene expression and methylation in osteosarcoma.
- Disputert:
- mai 2013
- Hovedveileder:
- Ola Myklebost
Antiangiogenic treatment in breast cancer - identifying responders and mechanisms driving resistance.
- Disputert:
- juni 2013
- Hovedveileder:
- Olav Engebråten
Novel therapeutic strategies in sarcoma.
- Disputert:
- mai 2013
- Hovedveileder:
- Ola Myklebost
Unraveling the complexity of protein networks
- Disputert:
- mai 2012
- Hovedveileder:
- Eivind Hovig
Prognostic biomarkers in colorectal cancer with emphasis on microRNA
- Disputert:
- desember 2012
- Hovedveileder:
- Kjersti Flatmark
Detection, isolation and molecular characterization of micrometastatis cells
- Disputert:
- juli 2011
- Hovedveileder:
- Øystein Fodstad
The role of the B7-H3 protein in cancer metastasis and resistance to chemotherapy
- Disputert:
- september 2011
- Hovedveileder:
- Øystein Fodstad
Novel approaches to the treatment of high grade sarcoma
- Disputert:
- mai 2011
- Hovedveileder:
- Ola Myklebost
- Solveig Pettersen Prosjektdeltaker
- Håkon Andre Ramberg Prosjektdeltaker
- Menaka Sathermugathevan Prosjektdeltaker
- Øystein Fodstad Prosjektdeltaker
- Leonardo Andrés Meza-Zepeda Prosjektdeltaker
- Ane Kristine Kongsgaard Rud Prosjektdeltaker
- Lina Prasmickaite Forsker (annen finansiering)
- Ildrid haltbakk Prosjektdeltaker
- Vigdis Nygaard Prosjektdeltaker
- Anna Wennerstrøm Prosjektdeltaker
- Else Munthe Forsker (annen finansiering)
- Kristin Andersen Forsker (annen finansiering)
- Johannes Eivind Hovig Prosjektdeltaker
- Kjersti Flatmark Prosjektdeltaker
- Kristin Austlid Tasken Prosjektdeltaker
- Ola Myklebost Prosjektdeltaker
- Gunhild Mælandsmo Forskningsgruppeleder
- Peder Braaland Doktorgradsstipendiat
- Helene Hartvedt Grytli Doktorgradsstipendiat
- Russell Castro Prosjektdeltaker
- Eva Wessel Stratford Postdoktorstipendiat
- Caroline Elisabeth Nunes Xavier Postdoktorstipendiat
- Jan Christian Bryne Prosjektdeltaker
- Tale Barøy Doktorgradsstipendiat
- Susanne Lorenz Postdoktorstipendiat
- Menaka Sathermugaghedan Prosjektdeltaker
- Alexandr Kristian Doktorgradsstipendiat
- Ellen Tenstad Postdoktorstipendiat
- Siri Juell Prosjektdeltaker
- Siri Tveito Postdoktorstipendiat
- Anna Berit Wennerström Prosjektdeltaker
- Anastasia Serguienko Doktorgradsstipendiat
eRapport er utarbeidet av Sølvi Lerfald og Reidar Thorstensen, Regionalt kompetansesenter for klinisk forskning, Helse Vest RHF, og videreutvikles av de fire RHF-ene i fellesskap, med støtte fra Helse Vest IKT
Alle henvendelser rettes til eRapport